XML 61 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 03, 2015
Sep. 27, 2014
Oct. 03, 2015
Sep. 27, 2014
Net sales [1] $ 449,004 $ 404,289 $ 1,291,891 $ 1,201,543
Cost of sales 271,822 241,909 784,258 730,013
Gross profit 177,182 162,380 507,633 471,530
Selling and distribution expenses 44,477 42,006 136,918 137,078
General and administrative expenses 52,675 40,428 140,745 122,834
Gain (Loss) Related to Litigation Settlement 0 (6,519) 0 (6,519)
Income from operations 80,030 [1] 86,465 [1] 229,970 218,137
Net interest expense and deferred financing amortization, net 4,224 3,895 12,021 12,051
Other (income) expense, net 1,941 993 6,136 2,053
Earnings before income taxes 73,865 81,577 211,813 204,033
Provision for income taxes 25,040 21,864 70,490 62,470
Net earnings $ 48,825 $ 59,713 $ 141,323 $ 141,563
Net earnings per share:        
Basic (in usd per share) $ 0.86 $ 1.05 $ 2.48 $ 2.50
Diluted (in usd per share) $ 0.86 $ 1.05 $ 2.48 $ 2.50
Weighted average number of shares        
Basic (in shares) 56,963 56,866 56,948 56,729
Dilutive common stock equivalents (in shares) 3 [2] 2 [2] 2 2
Diluted (in shares) 56,966 56,868 56,950 56,731
Comprehensive income $ 35,077 $ 47,108 $ 118,308 $ 132,372
[1] Non-operating expenses are not allocated to the operating segments. Non-operating expenses consist of interest expense and deferred financing amortization, foreign exchange gains and losses and other income and expense items outside of income from operations.
[2] There were no anti-dilutive equity awards excluded from common stock equivalents for any period presented.